Efficacy and safety of risankizumab versus methotrexate in patients with moderate-to-severe plaque psoriasis: results from IMMbrace, a randomized, double-blind, phase 3 study with an open-label extension period in Brazil.
Saved in:
| Title: | Efficacy and safety of risankizumab versus methotrexate in patients with moderate-to-severe plaque psoriasis: results from IMMbrace, a randomized, double-blind, phase 3 study with an open-label extension period in Brazil. |
|---|---|
| Authors: | Cestari TF; Department of Dermatology, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. Electronic address: tcestari@hcpa.edu.br., Souza CDS; Division of Dermatology, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil., Azulay-Abulafia L; Instituto de Dermatologia e Estética do Rio de Janeiro, Rio de Janeiro, Brazil., Romiti R; Department of Dermatology, Hospital das Clínicas, Universidade de São Paulo, São Paulo, SP, Brazil., Carvalho AVE; Department of Dermatology, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil., Silva de Castro CC; Discipline of Dermatology, Pontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil., Marques SA; Department of Infectology, Dermatology, Imaging Diagnosis and Radiotherapy, Faculty of Medicine, Universidade Estadual Paulista, Botucatu, SP, Brazil., Antonio JR; Discipline of Dermatology, Faculdade Estadual de Medicina de São José do Rio Preto, São José do Rio Preto, SP, Brazil., Fabrício L; Dermaology Service, Hospital Universitário Evangélico Mackenzie de Curitiba, Curitiba, PR, Brazil., Soliman AM; AbbVie Inc., North Chicago, Illinois, United States., Wu T; AbbVie Inc., North Chicago, Illinois, United States., Sinvhal R; AbbVie Inc., North Chicago, Illinois, United States., Stakias V; AbbVie Inc., North Chicago, Illinois, United States., Song AP; AbbVie Inc., North Chicago, Illinois, United States., Kalabic J; AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany., Martin N; AbbVie Inc., North Chicago, Illinois, United States; In memoriam., Oyafuso LKM; Department of Dermatology, Faculdade de Medicina de ABC, São Paulo, SP, Brazil. |
| Source: | Anais brasileiros de dermatologia [An Bras Dermatol] 2025 Mar-Apr; Vol. 100 (2), pp. 260-271. Date of Electronic Publication: 2024 Dec 07. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: Elsevier España, S.L Country of Publication: Spain NLM ID: 0067662 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1806-4841 (Electronic) Linking ISSN: 03650596 NLM ISO Abbreviation: An Bras Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
